Evolving classification systems for cancer cachexia: ready for clinical practice?

D Blum, A Omlin, K Fearon, V Baracos… - Supportive care in …, 2010 - Springer
Introduction Involuntary weight loss, the defining factor of cachexia, is a common
consequence of advanced cancer. Discussion This review summarizes the actual cachexia …

Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations

EA Laugsand, S Kaasa, P Klepstad - Palliative medicine, 2011 - journals.sagepub.com
The objectives were to review the existing literature on management of opioid-induced
nausea and vomiting in cancer patients and summarize the findings into evidence-based …

Symptom clusters in patients with advanced cancers

WY Cheung, LW Le, C Zimmermann - Supportive care in cancer, 2009 - Springer
Goals of work It has been observed that certain cancer symptoms frequently occur together.
Prior research on symptom patterns has focused mainly on inpatients, early stage cancers …

[HTML][HTML] Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study

A Omlin, D Blum, J Wierecky, SR Haile… - Journal of cachexia …, 2013 - Springer
Background Involuntary weight loss (IWL) is frequent in advanced cancer patients causing
compromised anticancer treatment outcomes and function. Cancer cachexia is influenced by …

Morphine-induced constipation develops with increased aquaporin-3 expression in the colon via increased serotonin secretion

R Kon, N Ikarashi, A Hayakawa, Y Haga… - Toxicological …, 2015 - academic.oup.com
Abstract Aquaporin-3 (AQP3) is a water channel that is predominantly expressed in the
colon, where it plays a critical role in the regulation of fecal water content. This study …

Pharmacological management of cancer pain in the elderly

S Mercadante, E Arcuri - Drugs & aging, 2007 - Springer
Existing studies indicate a high prevalence rate and poor management of cancer pain in the
elderly. Pain is often considered an expected concomitant of aging, and older patients are …

Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal …

S Wirz, M Wittmann, M Schenk, A Schroeck… - European Journal of …, 2009 - Elsevier
INTRODUCTION: The purpose of this trial was to evaluate the effect of long-term treatment
with oral sustained-release hydromorphone, transdermal fentanyl, and transdermal …

Opioid titration in cancer pain: a critical review

S Mercadante - European Journal of Pain, 2007 - Elsevier
Initiation of therapy with strong opioids is a challenging phase to obtain the maximum benefit
and to gain the patient's compliance. The approach could be different, depending on the …

Intensity and treatment of symptoms in 3,030 palliative care patients: a cross-sectional survey of the EAPC Research Network.

EA Laugsand, S Kaasa, F de Conno… - Journal of opioid …, 2009 - europepmc.org
Intensity and treatment of symptoms in 3,030 palliative care patients: a cross-sectional survey of
the EAPC Research Network. - Abstract - Europe PMC Sign in | Create an account …

[HTML][HTML] Behavioral risk factors of constipation in palliative care patients

T Dzierżanowski, A Ciałkowska-Rysz - Supportive Care in Cancer, 2015 - Springer
Background Constipation is frequently encountered in palliative care patients and remains a
significant therapeutic problem. The etiology of constipation is multifactorial. Nutritional and …